Cardiotoxicity perspective on the concurrent use of anti-HER2 agents and hypofractionated versus conventional fractionated locoregional radiotherapy in breast cancer.
Saved in:
| Title: | Cardiotoxicity perspective on the concurrent use of anti-HER2 agents and hypofractionated versus conventional fractionated locoregional radiotherapy in breast cancer. |
|---|---|
| Authors: | Tepetam H; Department of Radiation Oncology, University of Health Sciences, Kartal Dr. Lutfi Kırdar City Hospital, Istanbul, Turkey. htepetam78@yahoo.com.tr., Varan MP; Department of Radiation Oncology, University of Health Sciences, Kartal Dr. Lutfi Kırdar City Hospital, Istanbul, Turkey., Alomarı O; Hamidiye International School of Medicine, University of Health Sciences, Istanbul, Turkey., Yıldırım S; Department of Medical Oncology, University of Health Sciences, Kartal Dr. Lutfi Kırdar City Hospital, Istanbul, Turkey., Gedik D; Department of Radiation Oncology, University of Health Sciences, Kartal Dr. Lutfi Kırdar City Hospital, Istanbul, Turkey., Odabaş H; Department of Medical Oncology, University of Health Sciences, Kartal Dr. Lutfi Kırdar City Hospital, Istanbul, Turkey., Yaprak G; Prof. Dr. İlhan Varank Training And Research Hospital, Istanbul, Turkey., Taşlıyurt Ö; Department of Radiation Oncology, University of Health Sciences, Kartal Dr. Lutfi Kırdar City Hospital, Istanbul, Turkey., Gül ŞK; Department of Radiation Oncology, University of Health Sciences, Kartal Dr. Lutfi Kırdar City Hospital, Istanbul, Turkey. |
| Source: | BMC cancer [BMC Cancer] 2026 May 11; Vol. 26 (1). Date of Electronic Publication: 2026 May 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
